Skip to content

Effect on Satiety Response for China Meal Replacement Product

Effect on Satiety Response for China Meal Replacement Product

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029696
Enrollment
Unknown
Registered
2020-02-09
Start date
2020-03-23
Completion date
Unknown
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Satiety Response

Interventions

four groups :Ingested 4 different samples

Sponsors

Beijing Research Institute for Nutritional Resources
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Males or female aged 18-60 years old; 2. BMI 18.5 to 28kg/m2 (Normal weight group with BMI between 18.5 to 24 and Over-weight group with BMI between 24 to 28); 3. Healthy and taking no regular medications other than birth control or hormone replacement therapy. Testing in women should be controlled for menstrual phase (i.e. follicular); Able to provide informed consent and authorize release of relevant health information; No serious liver, kidney, digestive tract diseases and metabolic diseases such as diabetes as checked by medical examination; No blood lipid-related drugs used within 3 months, and agreed not to use drugs during the experiment; Willing and able to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant or nursing; 2. Gain or loss of > 4kg in the last 3 months; 3. Taking the prescription or over the counter weight loss medications or weight loss supplements; 4. Use of an investigational drug product within 30 days prior to the study period; 5. Extreme dietary habits (e.g. Zone diet or Atkins diet); 6. Dietary restraint on the Three Factor Eating Questionnaire score > 14; 7. Surgery or hospitalization in last 3 months; 8. History of severe or significant gastrointestinal disorder; 9. History of eating disorder (binge eating, anorexia, bulimia nervosa, etc.); 10. Diabetes mellitus (fasting glucose >126 mg/dL); 11. Allergy or reported GI intolerance to any of the foods used for the test meals; 12. Combining serious diseases such as heart, liver, kidney, gastrointestinal disorder and hematopoietic system, mentally ill patients; 13. Allergic or reported GI intolerance to any of the foods used for the test meals; 14. Prescription or over the counter weight loss medications / weight loss supplements; 15. Taking an investigational drug product within 30 days prior to the study period; 16. Excessive smoking or alcohol consumption (<15 cigarettes/d, <25g/d alcohol for men, or <15g/d alcohol/d for women); 17. Not intaking the samples according to the regulations, or things that affected the efficacy of or safety judgement, situations or uncompleted data judged by the PI that affected the trail 18. Not participation in any clinical trial within the past 30 days.

Design outcomes

Primary

MeasureTime frame
Glycemic index;Insulin Index;Satiety score;

Countries

China

Contacts

Public ContactJingyi Chang

Beijing Research Institute for Nutritional Resources

370453089@qq.com+86 18513700062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026